Evommune | Novel Therapies for Chronic Inflammatory Disease
Chronic inflammation destroys lives.
We’re here to do something about it.
Evommune was founded to discover and develop innovative therapies that target key drivers of chronic inflammatory disease.
Our Approach
We use leading edge science to target the root causes of inflammation.
Our Programs
Advancing a pipeline of differentiated product candidates for chronic inflammatory diseases.
Recent News
June 29, 2026
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Chronic Spontaneous Urticaria
May 7, 2026
Evommune Reports First Quarter 2026 Financial Results and Provides Business Highlights
April 6, 2026